LINH DONNELL: Open Payments
NPI 1861019408 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,707 in 174 payments from 18 companies in 2025. Trend: 2023 $1,936 · 2024 $2,324 · 2025 $3,707
Food & beverage: $3,599Education: $108
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 19 | $472 |
| UCB, Inc. | 30 | $452 |
| ABBVIE INC. | 22 | $446 |
| LEO Pharma Inc. | 12 | $385 |
| Galderma Laboratories, L.P. | 21 | $318 |
| Incyte Corporation | 12 | $287 |
| Arcutis Biotherapeutics, Inc. | 14 | $221 |
| PFIZER INC. | 11 | $219 |
| Regeneron Healthcare Solutions, Inc. | 5 | $207 |
| Lilly USA, LLC | 7 | $153 |
Products named: TREMFYA, Bimzelx, ADBRY, DUPIXENT, NEMLUVIO, OPZELURA, RINVOQ, Zoryve.
Industry payments across NY — which companies pay providers there.
